Tier 3 · Filer Universe

Atara Biotherapeutics, Inc.

ATRA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$9.70
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001604464
Liquidity rank
#4955
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$120.77M2025-12-310001193125-26-108361
Annual diluted EPS2.572025-12-310001193125-26-108361
Quarterly revenue$630,000.002026-06-300001193125-26-346885
Quarterly diluted EPS-0.322026-06-300001193125-26-346885

SEC EDGAR Frames batch generated 2026-08-23T13:58:52.206Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerISRG · Tier 1 peerHCA · Tier 1 peerAMGN · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames